Karslioglu Melisa Zisan, Sahin Afsun, Muftuoglu Orkun
Department of Ophthalmology, Koc University Hospital, Istanbul, Türkiye.
Department of Ophthalmology, Koc University Faculty of Medicine, Istanbul, Türkiye.
Beyoglu Eye J. 2023 Dec 1;8(4):239-246. doi: 10.14744/bej.2023.75983. eCollection 2023.
The objectives of the study are to show up the healing processes after anterior stromal puncture (ASP) in the cornea using confocal microscopy (IVCM) and to investigate the efficacy of ASP in the treatment of recurrent corneal erosion (RCE).
This is a prospective, non-randomized, consecutive series. Twenty-three eyes of 19 patients diagnosed with RCE were evaluated between March 2020 and January 2022. Outcome measures included age, sex, laterality, etiology of RCE, duration and recurrence of symptoms, additional treatments required, and complications. IVCM was performed on the same day, at 1 week, 1, and 6 month.
Mean age was 41.5±11.3 years, 63.2% of patients were female and 65.2% of eyes had unilateral involvement. Corneal trauma (56.5%) was the most common cause. Mean follow-up was 21.1 months (range 8-33). At the final follow-up, 69.5% of eyes were symptom free, 17.4% required a second ASP, and 13% needed a third ASP. At the 1st week, the epithelium became intact. An increase in activated keratocytes and dendritic cells (DCs) with beading of nerve fibers was observed. At 1 month, DCs and activated keratocytes were still present. At the 6 month, a scar was left. The superficial and basal epithelial cell formation and subbasal corneal nerve plexus returned to normal.
IVCM has a superiority in visualizing cornea at cellular level. After ASP which is a safe, practical, and cost-effective treatment option in paracentral or peripherally located RCE, IVCM may help the surgeon to better observe and understand the post-healing processes and explain the recurrences.
本研究的目的是利用共聚焦显微镜(IVCM)观察角膜前基质穿刺(ASP)后的愈合过程,并研究ASP治疗复发性角膜糜烂(RCE)的疗效。
这是一项前瞻性、非随机、连续系列研究。2020年3月至2022年1月期间,对19例诊断为RCE的患者的23只眼进行了评估。观察指标包括年龄、性别、患侧、RCE的病因、症状持续时间和复发情况、所需的额外治疗以及并发症。在同一天、1周、1个月和6个月时进行IVCM检查。
平均年龄为41.5±11.3岁,63.2%的患者为女性,65.2%的眼为单侧受累。角膜外伤(56.5%)是最常见的原因。平均随访时间为21.1个月(范围8 - 33个月)。在最后一次随访时,69.5%的眼无症状,17.4%需要第二次ASP,13%需要第三次ASP。在第1周时,上皮变得完整。观察到活化的角膜细胞和树突状细胞(DCs)增加,神经纤维有串珠样改变。在1个月时,DCs和活化的角膜细胞仍然存在。在6个月时,留下了瘢痕。浅表和基底上皮细胞形成以及角膜基质下神经丛恢复正常。
IVCM在细胞水平观察角膜方面具有优势。ASP是治疗旁中心或周边性RCE的一种安全、实用且经济有效的治疗选择,IVCM可帮助外科医生更好地观察和理解愈合后过程,并解释复发情况。